Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Corning Incorporated
Will Genus Claims Be Resuscitated? Supreme Court To Decide In Amgen PCSK9 Patent Dispute
High court will consider the standard for determining if a patent covering a group of related chemicals is enabled in Amgen v. Sanofi. It denies Juno petition seeking review of standard for written description of an invention in CAR T-cell patent suit against Kite.
Lilly CEO: Monoclonal Antibody Companies Should Share Coronavirus Manufacturing Capacity
David Ricks says a consortium of companies will be needed to ensure enough doses of the successful candidates are available.
Device/Diagnostics Quarterly Deal Statistics, Q1 2014
Device financing dropped more than 40% to $714 million in Q1; Smith & Nephew’s $1.7 billion acquisition of ArthroCare overshadowed acquisitions. Diagnostics companies raised $568 million, a 34% increase over 2013’s final quarter; nonprofits provided assets to diagnostics firms in multiple licensing arrangements.
Life Science Start-Ups: Venture Funding, May 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced March through April 2014.
- Other Names / Subsidiaries
- Corning Inc.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.